Clinical Trials Logo

Clinical Trial Summary

The goal of this project is to evaluate how aerobic training impacts eyeblink conditioning as a proxy for cerebellar dependent motor learning. The newly developed smartphone application, iBlink, will be used to test participants at home in an effort to improve recruitment and increase the sample size of the study. The investigators hypothesize that aerobic training, but not balance training, will improve eyeblink conditioning in participants with spinocerebellar ataxias. The current study focuses on Aim 3 of this project.


Clinical Trial Description

Spinocerebellar ataxias are a group of disorders that cause severe disability due to progressive incoordination. With no FDA approved medications, there is a critical need to find effective treatments. The research team has shown that high intensity aerobic training, defined as 30-minute training sessions, 5x per week at above 80% maximum heart rate, is a potential treatment, causing clinically significant improvements in ataxia symptoms at 6-months compared to home balance training. However, it is unclear whether aerobic training induces neuroplastic changes within the damaged cerebellum to enhance motor learning, or if improvements are primarily due to increased leg strength and endurance which help compensate for balance deficits. In order to investigate the impact of aerobic training on cerebellar-dependent motor learning, the research team proposes using eyeblink conditioning. In this paradigm, an unconditioned stimulus, such as a flash of light, is used to elicit a reflexive blink. When a neutral conditioned stimulus, such as a tone is paired repeatedly with the flash of light, individuals learn to blink their eyes in response to the tone (conditioned response). The magnitude of learning is gauged by the percentage of trials that result in a conditioned response or the mean change in conditioned response amplitude. Unfortunately, eyeblink conditioning is not often utilized in clinical studies due to the high cost, extensive programing and data management skills needed to interpret data, and the need for multiple in-person visits to ascertain the magnitude of learning. In an effort to overcome these barriers, the research team's collaborators recently developed iBlink, an application for the smartphone that can test eyeblink conditioning remotely. This application is low cost, straight-forward for participants to use at home, and produces easily interpretable data. Moreover, the research team has shown that iBlink can be used to determine changes in eyeblink conditioning due to aerobic training in healthy individuals. Thus, the goal of this pilot study will be to use the iBlink application to study the impact of exercise on eyeblink conditioning as a proxy for motor learning in spinocerebellar ataxias. Aim 1) To determine if individuals with spinocerebellar ataxias have deficits in eyeblink conditioning using iBlink. Prior studies indicate that individuals with spinocerebellar ataxia 3, 6, and Fredrich's ataxia have impaired eyeblink conditioning, but it is unclear whether this is true for other ataxia types. Thus, the investigators will recruit individuals with a variety of spinocerebellar ataxia types and compare eyeblink conditioning to age and sex-matched healthy controls (baseline condition). The investigators hypothesize that all participants with spinocerebellar ataxia will have impaired eyeblink conditioning compared to healthy controls, but participants with spinocerebellar ataxia types that cause oculomotor deficits will have more impairment than individuals with other ataxia types. Aim 2) Impact of acute aerobic exercise on eyeblink conditioning in spinocerebellar ataxias. Acute aerobic exercise enhances the conditioned response rate in healthy individuals, and this enhancement is larger in physically active individuals when compared to sedentary people. For this study, participants with spinocerebellar ataxia will be classified as sedentary or physically active using the Global Physical Activity Questionnaire. Next, participants will be asked to perform 30-minutes of acute aerobic training at moderate intensity (~75% max heart rate) for 5 consecutive days. Immediately after each training, participants will use iBlink and results will be compared to baseline condition (Aim 1). The investigators hypothesize that all participants with ataxia will have improvement in eyeblink conditioning (increased mean change in conditioned response amplitude) after acute aerobic training, but those who are more physically active will have more enhancement with exercise. Aim 3) Impact of long-term aerobic exercise on eyeblink conditioning in spinocerebellar ataxias. Participants will be randomized to either home balance or aerobic training for 6-months. Participants will undergo eyeblink conditioning using iBlink at baseline, 3-, 6-, and 9-months. Ataxia symptoms will also be determined using the remote video Scale for the Assessment and Rating of Ataxia (SARAhome) at each assessment. The investigators hypothesize that individuals in the aerobic group will have improved eyeblink conditioning compared to the balance training group. Furthermore, the investigators expect that improvements in SARA scores will correlate with improvements in eyeblink conditioning, supporting that the aerobic training is inducing neuroplastic changes within the cerebellum. Clinical Significance: Aerobic training demonstrates promise as a treatment for spinocerebellar ataxias, but the mechanism of improvement is unclear. This study addresses if aerobic training can enhance motor learning in individuals with cerebellar degeneration. It will also help validate the use of the iBlink application as an easy, inexpensive, and remote way to test eyeblink conditioning. Thus, eyeblink conditioning can be more readily used to monitor spinocerebellar ataxias or be used as an outcome measure in future clinical studies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06177626
Study type Interventional
Source Columbia University
Contact Scott Barbuto, MD, PhD
Phone 212-305-3535
Email sb3779@cumc.columbia.edu
Status Not yet recruiting
Phase N/A
Start date June 1, 2024
Completion date September 1, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05973019 - rTMS Improves Functions in Spinocerebellar Ataxia N/A
Completed NCT04837027 - Effect of Training on Brain Volume in Ataxia N/A
Completed NCT04595578 - Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia N/A
Completed NCT03745248 - Aerobic Exercise, Balance Training, and Ataxia N/A
Completed NCT05951010 - Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38 N/A
Completed NCT01037777 - RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Completed NCT00136630 - Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Completed NCT03687190 - Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients N/A
Active, not recruiting NCT03701399 - Troriluzole in Adult Subjects With Spinocerebellar Ataxia Phase 3
Completed NCT05436262 - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia N/A
Recruiting NCT04231487 - Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Withdrawn NCT04301284 - Study of CAD-1883 for Spinocerebellar Ataxia Phase 2
Not yet recruiting NCT06397274 - Stemchymal® for Polyglutamine Spinocerebellar Ataxia Phase 2
Recruiting NCT04529252 - Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Completed NCT05621200 - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia N/A
Completed NCT03701776 - Ataxia and Exercise Disease Using MRI and Gait Analysis N/A
Completed NCT03120013 - Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia N/A
Active, not recruiting NCT03408080 - Open Pilot Trial of BHV-4157 Phase 3
Active, not recruiting NCT02960893 - Trial in Adult Subjects With Spinocerebellar Ataxia Phase 2/Phase 3
Completed NCT04153110 - Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia N/A